SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
246Rnai IV therapy coupled with other gene therapies? fiordiliji.ashley-pub.com Tzeta1961-7/8/2004
245<i>Very nice chart </i> Obviously, I don't know how to read a ctom pope-7/1/2004
244Thanks. Tuck's original post for this thread mentions Qiagen, saying that &qtom pope-7/1/2004
243Thanks, Tom. More on QIAGEN. Cheers, Thomas QIAGEN Completes Management BuyoThomas-7/1/2004
242VENLO, The Netherlands, June 30 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ: Qtom pope-6/30/2004
241Well, I don't think it undercuts the Isis deal, and ALNY will in all likelihtuck-6/30/2004
240not so concerned about how much they get from this deal; my question really is bob zagorin-6/30/2004
239Hard to say how much Isis could get from this. I think ALNY's MacD program tuck-6/30/2004
238for reference, here's the march release on the isis-alnylam alliance... Isibob zagorin-6/30/2004
237i posted that news release on the isis thread. anyone care to comment on how thabob zagorin-6/30/2004
236The MacD competition heats up. Merck - Alnylam deal. Cheers, Thomas Merck, AlnThomas-6/30/2004
235[siRNA versus hematologic malignancies -- Novartis] >>J. Clin. Invest. 11tuck-6/24/2004
234Good overview of advances in RNA delivery technology from MIT Technology Review Thomas-6/17/2004
233Greetings to all, Courtesy of Google news alerts, see below for an announcementThomas-6/17/2004
232I do follow Vical a bit,and my Mom owns a bit (significantly under water on thattuck-6/14/2004
231thanks it was good for me to reread that partnership release. another co. i follbob zagorin-6/14/2004
230Yes, but I don't think it has much to do with delivery technologies: Messagtuck-6/14/2004
229didn't ALNY just announce a major partnership with ISIS?bob zagorin-6/14/2004
228[Mirus -- Delivery: Recharging cationic DNA complexes with highly charged polyantuck-6/14/2004
227This company is involved with getting things to cross the BBB that normally can&tuck-6/10/2004
226Sirna is being vague about its delivery methods; if the numbers fit the hype, wetuck-6/7/2004
225[Protection against lethal influenza virus challenge by RNA interference in vivotuck-6/6/2004
224Forbes: The Believer Seth Lubove, 05.24.04 Steve Kriegsman is trying to revivmopgcw-6/1/2004
223Riboswitches-- The Scientist article: Snip: With implications and applications Thomas-5/26/2004
222Bob, no idea on implications for atugen-ISIS partnership. Sorry. Courtesy ofThomas-5/19/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News